Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
N-glycolyl-containing gangliosides are a specific subtype of gangliosides characterized by the presence of N-glycolylneuraminic acid (NeuGc) instead of the more common N-acetylneuraminic acid (NeuAc) found in human tissues. They are complex glycosphingolipids composed of a ceramide lipid backbone (embedded in the plasma membrane), an oligosaccharide chain, and one or more N-glycolylneuraminic acid (NeuGc) residues. The key distinguishing feature is the presence of NeuGc instead of NeuAc, with the NeuGc form containing an additional hydroxyl group compared to the N-acetyl form.
Modulate receptor activity through lateral interactions; promote formation of signaling complexes by clustering receptors in membrane microdomains; serve as binding sites for pathogens; regulate growth factor receptor signaling pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on N-glycolylneuraminic acid-containing gangliosides (NeuGc gangliosides).